Regeneron

Regeneron is a leading biotechnology company focused on inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron has a unique ability to repeatedly translate scientific discoveries into approved treatments and product candidates in development. Their medicines and pipeline are designed to address a wide range of diseases, including eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies. The company also leverages data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling them to identify innovative targets and complementary approaches to potentially treat or cure diseases. Regeneron's commitment to science, innovation, and a culture of collaboration has led to numerous successful medicines and a strong reputation within the biotechnology industry.

Regeneron offers a hybrid work model for many of its roles, allowing employees to work both on-site and remotely. The specific days required on-site vary by role, and some positions are fully remote. Regeneron also offers relocation assistance, demonstrating a willingness to accommodate employees who may need to move for a new role.

Regeneron offers a comprehensive benefits package designed to support employee well-being in various aspects of life. Benefits often include health and wellness programs, fitness centers, equity awards, annual bonuses, and paid time off for eligible employees at all levels. Additionally, the company provides support for mental and family well-being, with offerings such as an Employee Assistance Program, paid parental leave, fertility and adoption assistance, childcare discounts, and elder care. Financial benefits include stock grants, 401(k) company match, flexible spending accounts, health savings accounts with employer contributions, life insurance, disability benefits, income protection benefits, tuition reimbursement, and a student loan paydown program.

Regeneron Pharmaceuticals is a leading biotechnology company dedicated to the discovery, development, and commercialization of life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron prioritizes scientific innovation and leverages proprietary technologies to create and deliver treatments for a wide range of diseases, including eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. Their commitment extends beyond the lab, encompassing responsible business practices, STEM education initiatives, and a culture that fosters diversity, equity, and inclusion.

Regeneron promotes a culture that is driven by scientific excellence and innovation, with a focus on collaboration and teamwork. The company values integrity, prioritizes patient well-being, and encourages employees to take on challenging problems with a "make it happen" mentality. The company also emphasizes a strong sense of community, with programs that support local communities and foster the next generation of STEM leaders.

Regeneron believes that a better workplace leads to better science, which ultimately leads to a better world. Their Diversity, Equity, and Inclusion strategy is "Better Workplace, Better Science, Better World" and is embedded in their mission and culture. The company focuses on fostering a culture of inclusion by providing mandatory trainings for senior management and building a network of employee-led advocacy groups. Regeneron is also committed to increasing diverse representation in leadership through hiring diverse talent, reducing bias in job descriptions and partnering with diversity-focused student organizations. Lastly, they aim to build equitable communities by investing in STEM outreach programs, donating to racial equality causes, and accelerating efforts to increase diversity in clinical trials.